FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Europe

Biotech startups in Europe

Updated 16 Nov 2026

Reset
Biotech startups in Europe
One-time CSV
  • 2,201 funded companies, 1,317 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~europe.csv2,201 rows × 18 columns
CompanyCityLast roundAmountDate
bit.bioCambridgeSeries D$25.0M2026-11-04
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Basecamp ResearchLondonSeries C$140.0M2026-09-23
BiolevateParisSeries A$34.4M2026-09-21
BiorceBarcelonaSeries A$52.0M2026-02-02
BrainomixOxfordSeries C$6.5M2026-02-24
WhiteLab GenomicsParisSeries B$26.0M2026-10-05
MicrobioticaCambridgeSeries C$47.9M2026-10-16

8 rows of the CSV in 5 of its 18 columns.

2,201
Startups
$27.5B
Total raised
273
Funded in the last 12 months
$5.1B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 2,201
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Cambridge, United Kingdom Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016
Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh, United Kingdom Series A $3.3M 2026-11-02 $17.4M Innovate UK, Scottish Enterprise, Old College Capital +2 11 to 50 2020
Onego Bio Onego Bio produces egg protein through fermentation as a food ingredient. Biotech Helsinki, Finland Series B $28.0M 2026-10-26 $100.6M European Innovation Council, Business Finland, Tesi +2 11 to 50 2022
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M European Innovation Council, Fraunhofer Venture, CK Venture Capital 11 to 50 2017
Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Cambridge, United Kingdom Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London, United Kingdom Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
WhiteLab Genomics WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. Artificial intelligence Paris, France Series B $26.0M 2026-10-05 $36.5M Y Combinator, Omnes Capital 11 to 50 2019
Aptadir Therapeutics Aptadir Therapeutics develops RNA-based therapies for Myelodysplastic Neoplasms. Biotech Milan, Italy Seed $45.5M 2026-09-29 $47.1M CDP Venture Capital, Angelini Ventures 1 to 10 2024
Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London, United Kingdom Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
Biolevate Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. Artificial intelligence Paris, France Series A $34.4M 2026-09-21 $40.7M Bpifrance, EQT Ventures 11 to 50 2024
Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen, The Netherlands Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014
BioFluff BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. Biotech Paris, France Seed $2.5M 2026-09-02 $3.2M SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 1 to 10 2022
Amyl Therapeutics Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. Biotech Liège, Belgium Series A $9.6M 2026-09-01 $44.0M Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 1 to 10 2020
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne, Switzerland Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
Pixelgen Technologies Pixelgen Technologies develops technologies for biomedical research and diagnostics. Biotech Stockholm, Sweden Series B $15.5M 2026-08-20 $43.5M Industrifonden, Navigare Ventures, Colibri Ventures +1 11 to 50 2020
Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden, The Netherlands Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen, Germany Series B $7.3M 2026-08-18 $10.0M HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 11 to 50 2012
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
NOUS NOUS develops biotech ingredients for food, beverage, and nutraceutical products. Biotech Lomazzo, Italy Seed $2.7M 2026-07-15 $3.0M Eatable Adventures 1 to 10 2023
En Carta Diagnostics En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. Biotech Paris, France Seed $3.4M 2026-07-10 $7.3M CentraleSupélec Venture 11 to 50 2022
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London, United Kingdom Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
smartbax Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. Biotech Munich, Germany Seed $5.5M 2026-06-30 $7.5M HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund 1 to 10 2021
Automata Automata provides laboratory automation software and hardware to increase efficiency in scientific workflows. Artificial intelligence London, United Kingdom Series C $45.0M 2026-06-25 $144.8M Octopus Ventures, Firstminute Capital, Hummingbird Ventures +1 101 to 250 2015
Graph Therapeutics Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. Artificial intelligence Klosterneuburg, Austria Seed $5.0M 2026-06-22 $9.4M SquareOne Venture Capital, Merantix Capital 1 to 10 2024
Apoha Apoha is a start-up that has not yet publicly launched. Biotech London, United Kingdom Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
Imperagen Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. Artificial intelligence Manchester, United Kingdom Seed $6.7M 2026-05-20 $11.0M IQ Capital, Northern Gritstone 11 to 50 2021
Alcolase Alcolase is a Danish life science start-up developing treatments for alcohol flushing. Biotech Copenhagen, Denmark Seed $1.7M 2026-05-18 $2.6M Antler 1 to 10 2021

Table 1. Biotech startups in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 2,201.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Cambridge, United Kingdom Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
2 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
3 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
4 Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London, United Kingdom Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
5 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
6 Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden, The Netherlands Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
7 ADCendo ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. Biotech Copenhagen, Denmark Series C $75.0M 2026-04-14 $324.6M RA Capital Management, Novo Holdings, Gilde Healthcare +2 51 to 100 2017
8 Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich, Germany Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
9 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
10 Biorce Biorce develops a clinical AI assistant that speeds up and lowers the cost of clinical trials. Artificial intelligence Barcelona, Spain Series A $52.0M 2026-02-02 $61.5M Plug and Play, YZR Capital, Outsized Ventures +1 11 to 50 2024

Table 2. Biotech startups in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 79 4% 5 Computomics, smartbax, Tacalyx
2 Venture Kick Startup incubator Schlieren, Switzerland 46 2% 2 Adaptyv Biosystems, Genknowme
3 Innovate UK Entrepreneurship program Swindon, United Kingdom 30 1% 8 Bioliberty, Apoha, CellCentric
4 Bpifrance Government investment office Maisons-alfort, France 23 1% 2 Biolevate, Standing Ovation
5 KfW Government investment office Frankfurt, Germany 22 1%
6 European Innovation Council Startup accelerator Brussels, Belgium 21 1% 5 Onego Bio, Cellbox Solutions, Computomics
7 Sofinnova Partners Venture capital firm Paris, France 16 1% 3 T-Therapeutics, Mironid, Bon Vivant
8 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 15 1% 1 FoRx Therapeutics
9 Forbion Capital Partners Private equity firm Naarden, The Netherlands 14 1% 1 Kynexis
10 Novo Holdings Corporate venture arm Hellerup, Denmark 14 1% 2 Windward Bio, ADCendo
11 SOSV Venture capital firm Princeton, United States 14 1% 3 Sava Technology, BioFluff, FluoSphera
12 Andera Partners Private equity firm Paris, France 13 1% 1 Exciva
13 Bayern Kapital Venture capital firm Landshut, Germany 13 1% 1 mbiomics
14 MassChallenge Startup accelerator Boston, United States 12 1% 1 Octarine Bio
15 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 11 0% 3 smartbax, Tacalyx, Brainomix

Table 3. Biotech startups in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 1,562 71% $24.5B
Software 368 17% $2.2B
Artificial intelligence 213 10% $1.7B
Hardware 98 4% $530.5M
Fintech 31 1% $44.9M
Education 26 1% $389.7M
Cybersecurity 18 1% $31.5M
Energy 16 1% $57.5M
Commerce 8 0% $15.7M

Table 4. Biotech startups in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 271 12% $474K
Seed 1,040 47% $1.8M
Series A 488 22% $11.3M
Series B 249 11% $20.0M
Series C 111 5% $25.0M
Series D+ 42 2% $23.7M

Table 5. Biotech startups in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 638 29%
France 270 12%
Germany 265 12%
Switzerland 207 9%
The Netherlands 124 6%
Spain 103 5%
Denmark 86 4%
Italy 79 4%
Sweden 66 3%
Belgium 66 3%
Ireland 53 2%
Austria 50 2%

Table 6. Biotech startups in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 242 11%
Paris 93 4%
Cambridge 85 4%
Berlin 48 2%
Oxford 47 2%
Barcelona 45 2%
Copenhagen 41 2%
Basel 39 2%
Lausanne 29 1%
Munich 26 1%
Milan 25 1%
Zürich 25 1%

Table 7. Biotech startups in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 12 4% $341.2M
October 2026 23 8% $686.0M
September 2026 43 16% $489.4M
August 2026 12 4% $418.9M
July 2026 14 5% $212.3M
June 2026 23 8% $539.1M
May 2026 20 7% $576.7M
April 2026 21 8% $386.5M
March 2026 27 10% $339.0M
February 2026 19 7% $193.0M
January 2026 27 10% $403.9M
December 2025 21 8% $314.0M
November 2025 11 4% $156.5M

Table 8. Biotech startups in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 241 11% $4.6B
2025 274 12% $4.8B
2024 268 12% $4.0B
2023 204 9% $2.0B
2022 194 9% $1.9B
2021 167 8% $2.3B

Table 9. Biotech startups in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 237 11%
2020 to 2022 489 22%
2015 to 2019 749 34%
2010 to 2014 358 16%
Before 2010 349 16%

Table 10. Biotech startups in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 1,085 50%
11 to 50 901 42%
51 to 100 105 5%
101 to 250 43 2%
251 to 500 11 1%
501 to 1,000 4 0%
1,001 to 5,000 4 0%
5,001 to 10,000 1 0%
10,001 or more 2 0%

Table 11. Biotech startups in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Europe are on the list?
2,201, in the file dated 16 November 2026. 273 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 2,201 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Europe: 2,201 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Europe by funding stage

Other sectors in Europe

Biotech startups elsewhere

Cite: FundingWatcher, 2,201 funded biotech companies in Europe, 16 November 2026. https://fundingwatcher.com/startups/biotech/europe/